Introduction 27
Bacterial sequencing of clinical isolates has been used in many settings, including for virulence 28 determinants 1-4 , population structure 5 6 and outbreak investigations [7] [8] [9] [10] . Almost exclusively current 29 applications of sequencing rely either upon culture or targeted amplification imparting a diagnostic 30 bias towards known pathogens and bacteria with known and relatively simple growth requirements. 31
Bacterial whole genome sequencing is most often performed at reference or research centres to study 32 population structures and evolution, with results rarely available in a clinically actionable time. One 33 exception to this is the application of next generation sequencing to the diagnosis of tuberculosis 11, 12 , 34
where WGS was shown, in some cases, to be quicker than current routine methods for predicting 35 resistance; however this process still relies on culturing of the bacteria prior to sequencing. 36
Direct from sample sequencing of pathogens using an untargeted (metagenomic) approach has the 37 potential to lower turnaround times and lower diagnostic bias. Metagenomic sequencing techniques 38
have already been applied to ecological studies [13] [14] [15] [16] , gut microbiomes [17] [18] [19] and investigation and 39 identification of viruses [20] [21] [22] [23] . 40
Bacteraemia is a major global cause of morbidity and mortality, with a large range of aetiologies and 41 is a particular problem in healthcare settings 24, 25 . The current microbiological diagnostic process is 42 culture based often involving specialised equipment, with time to positivity varying due to aetiology 43 and pathogen load. Although recent advances in MALDI-TOF processing has allowed direct 44 identification of bacteria from positive blood cultures 26, 27, 28 , antibiotic sensitivities take a further 18 45 hours from pure bacterial cultures. The direct application of whole genome sequencing to blood 46 samples would allow rapid pathogen diagnosis, along with simultaneous pathogen typing and 47 genotypic resistance prediction. Furthermore, by applying an unbiased pathogen detection method the 48 diagnostic bias would be lowered. 49
A two-stage host cell removal was performed, firstly red blood cells were removed using HetaSep®, 50 previously used to isolate nucleated cells in the blood, particularly granulocytes. Secondly a selective 51 white blood cell lysis was undertaken using saponin 29 in order to release intracellular pathogens and 52 aid in host nucleic acid removal. 53
To directly sequence pathogens, present at low levels (as few as 1 bacterial cell per ml blood) such as 54 those found in sterile site infections an unbiased and high-fidelity amplification enzyme is needed. 55
Multiple displacement amplification (MDA) using ɸ 29 is an alternative method to PCR for the 56 production of DNA in high enough amounts for sequencing. ɸ 29 MDA has been applied to samples 57 with very low starting DNA amounts from single cells (both prokaryotic and eukaryotic) and provided 58 DNA in levels high enough to perform sequencing 30, 31 . It has been demonstrated that this method is 59 3 suitable for use with single bacterial cells 30, 31 and more recently malaria parasites directly from blood 60 samples 32 . The aim of this study was to devise a process to allow same day untargeted bacterial 61 sequencing to be performed on DNA directly isolated from a bacteria spiked blood model. 62
Methods 63
Isolates 64
Clinical isolates of E. coli and S. aureus were collected from the Royal Free Hospital Hampstead, 65 where they had been stored at -80 o C after isolation from septic patients. E. coli and S. aureus are 66 common aetiologies of blood stream infections, representing different cell wall types and cell 67 morphologies. Phenotypic data was produced using the BD phoenix and was retrieved from final 68 hospital reports. Bacteria were cultured on Horse blood agar at 37 o C overnight. 69
Spiking and isolation process 70
Spiked samples were set up by adding an estimated ten bacterial cells of the clinical isolate of S. 71 aureus or E. coli calculated using serial dilutions to 1ml horse blood. The workflow depicted 72 inError! Reference source not found. μl 5% saponin was added to a final 2% solution, and incubated at room temperature for 5 minutes. 75 700μl sterile water was added for a water shock and incubated at room temperature for 30 seconds 76 before salt restoration with the addition of 21μl 5M NaCl. The sample was centrifuged at 4000xg for 77 5 minutes and the supernatant discarded before addition of 2 μl turbo DNase1 and 5 μl of 10x buffer 78 (Ambion). The sample was vortexed and incubated at 37 o C for 15 minutes EDTA was added to a final 79 concentration of 15nM. The sample was then centrifuged for 5 minutes at 4000xg and the supernatant 80 removed and discarded. The pellet was washed in decreasing volumes of PBS, initially 200 μl then 81 100 μl followed by 20 μl with each stage being centrifuged at 6000xg for three minutes. The final 82 pellet was suspended in 4 μl sterile PBS. 83
Bacterial survival 84
To check for bacterial survival at each stage of processing 13 spiked samples were set up and 85 processed. At the end of each processing stage (Table 1) one sample was cultured and colony counts 86 performed. This was repeated three times for the E. coli and S. aureus isolate. 87
DNA extraction and Amplification 88
Extraction was performed using alkaline method; briefly cell suspensions were added to 200 mM 89 potassium hydroxide (Qiagen) and 50mM dithiothreitol (Qiagen) and incubated at 65 o C for 10 90 minutes. The reaction was then neutralised using neutralisation buffer (Qiagen), briefly vortexed and 91 placed on ice. 92
Amplification was performed using ɸ29 MDA (Repli-g Single Cell Kit Qiagen). A master mix was 93 prepared on ice in a total volume of 40 µl, with 29 µl reaction buffer, containing endonuclease 94 resistant hexamer primers and 2 µl (40 U) of ɸ29 polymerase (Qiagen, REPLI-g Single Cell Kit). The 95 extracted DNA was then added to the master mix and the sample was then incubated at 30 0 C for 2 96 hours, and the reaction stopped by heating to 65 0 C for 3 minutes. 97
Sequencing 98
DNA was quantified using Qubit BR kit and 3 µg of ɸ29 MDA DNA was de-branched using S1 99 nuclease in a 90 µl reaction as follows, 3 µl 10x buffer, 3 µl 0.5M NaCl, 10 µl S1 nuclease (1U/ µl) 100 with water to make the volume to 90µl. The digestion reaction was left at room temperature for 30 101 minutes and the enzyme deactivated by incubating at 70 o C with 6 µl 0.5M EDTA. The DNA was then 102
fragmented by nebulisation at 30psi for 180 seconds. The DNA was sequenced using the 454 Junior 103 using the manufacturer's recommended methods. 104
Data analysis 105
Data analysis was performed in three stages, first host and contaminating reads were removed before 106 abundance trimming, secondly reads were classified using lowest common ancestor (LCA) analysis 107 and finally classified reads were assembled and analysed. 108
Initially reads were mapped using Newbler (Roche diagnostics) standard parameters against host and 109 a local contamination library consisting of sequenced negative controls and reads identified as 110 contamination in previous runs. Unmapped reads were written into a new fastq file using a custom 111 python script and taken forward for further analysis. The remaining reads were abundance trimmed 112 using Khmer 33 using two passes to a maximum depth of 50, to remove over represented reads 113 produce by the ɸ29 MDA method. Following this the reads were error trimmed using Prinseq 34 , with 114 ends being trimmed to a Q20 cut off. 115
Blastn was then used to assign the reads against the NCBI nt database. Once completed lowest 116 common ancestor (LCA) analysis was performed using MEGAN 35 , and reads associated with the 117 bacterial species of interest were extracted to a new fastq file. These reads were then de novo 118 assembled using standard parameters in SPAdes 36 assembly outputs were assessed using QUAST 119 (Quality Assessment Tool for Genome Assemblies) 34 . Reference assemblies were performed using the 120 closest reference sequence identified using the LCA analysis. Antibiotic prediction was performed 121 using Mykrobe 11 for S. aureus and ResFinder 37 for E. Coli using the de novo assembled reads. 122
Results 123

Sample processing 124
When the full blood processing method was applied to E. coli and S. aureus, good survival rates were 125 found for both bacteria through-out all stages. Details of survival at each stage of processing can be 126 found in Table 1 127
Sequencing results S. aureus 128
After processing and DNA amplification the concentration of DNA was 139ng / µl , after sequencing 129 the number of reads passing basic filter was 128,500. Once known contaminants were removed and 130 error and abundance trimming complete 124,145 reads remained. After reads were assigned using 131
Blastn and LCA analysis performed using MEGAN, 92.3% of reads were classified. 72.22% of reads 132 were classified as Staphylococcus species and 62.1% reads were identified as S. aureus. 6.76% of 133 the reads were identified as the genus Equus, and 1.72% were identified as Parascaris equorum. 134
Remaining reads were not classified above the Class level in LCA analysis. When examining the S. 135 aureus reads closer 4254 reads were identified to the subspecies level, (Staphylococcus aureus subsp. 136 aureus HO 5096 0412), this subspecies has a complete genome available (GenBank 137 GCA_000284535.1) and was used as a reference for reference mapping. Reference mapping covered 138 92% of the reference genome. When the reads identified as Staphylococcus using the LCA analysis 139 were extracted and the reads de novo assembled 1212 contigs were produced. When this was 140 compared to the same reference as the reference assembly 83% of the genome was covered with 10 141 misassemblies and a N50 of 3882. Mykrobe analysis was performed using the de novo assembly gave 142 genotypic result for 12 antibiotics. When comparing the genotypic and phenotypic (BD Phoenix™) 143 results matched in 11 of the 12 antibiotics ( Table 2) . The results for ciprofloxacin were inconclusive 144 in genotypic tests, but resistant by phenotypic methods. 145
Sequencing results E. coli 146
After processing and amplification, the DNA concentration of the sample was 143 ng/ µl. Post 147 sequencing 173,597 reads passed the initial filter, once contaminants were removed and the reads 148 error and abundance trimmed 170,243 reads remained. Overall 73% of all reads remaining after the 149 analysis pipeline were identified as E. coli. 31959 (18%) reads had no identity. Unlike S. aureus it 150
was not possible to type the E. coli, as 150 reads were assigned to O7:K1 and 211 reads were assigned 151 to JJ1886. Reads which were identified as Enterobacteriaceae, Escherichia and E. coli by BLAST 152 and LCA analysis were extracted from the fastq produced after pipeline completion. The genome of 153 JJ1886 was available from the Integrated Microbial Genomes database (ID 2558309052), and the 154 chromosomal sequence was used as the reference against which the extracted reads were assembled. 155
After reference mapping assembly 93.5% of the genome was covered. When the reads were de novo 156 6 assembled, 89% of the same reference was covered in 1334 contigs. The de novo assembly was used 157 to identify several resistance markers using ResFinder. The resistance markers included dfrA, 158 conferring trimethoprim resistance, gyrA conferring resistance to fluoroquinolones. mdtK is an efflux 159 pump conferring resistance to norfloxacin and blaCMY-2 which is an AmpC, conferring resistance to 160 beta-lactams including cephalosporins. Additionally, eight drug efflux systems were identified. These 161 results were concordant to the phenotypic data (Table 2) . 162
Discussion 163
Direct diagnostics using WGS from clinical samples would, in many ways, provide the ideal 164 diagnostic method. By providing all the information from whole genome data with the speed of direct 165 sample testing. There are increasing references to using metagenomic approaches to detect pathogens 166 directly from clinical samples. A recent study, using the Oxford Nanopore Technologies MinION to 167 sequence directly from TB smear positive respiratory samples, demonstrated it was possible to get 168 phenotypically concordant results from sequencing in 12.5 hours 38 . Direct sequencing from 169 orthopaedic device infections showed that a metagenomic sequencing approach gave species level 170 specificity and sensitivity of 88% compared to traditional culture techniques 39 . In a study of ocular 171 eye fluid samples, it was possible to match 9/12 bacteria using metagenomic sequencing compared to 172 traditional culture techniques, with the additional advantage of being able to obtain sequence types 173 and antibiograms for some of the identified pathogens 40 . Whilst these studies provide good evidence 174 of the application of metagenomic sequencing, applying these methods directly to blood still has 175 various are various obstacles, including low pathogen numbers, high host background and difficulty 176 in interpreting genotypic data. 177 178 Here, a model was prepared to demonstrate the potential for direct from sample sequencing from 179 whole blood. This method allows DNA to be ready within 3.5 hours of sample receipt, including 180 bacterial isolation and DNA amplification. Once the DNA is prepared it could be processed on any 181 sequencing platform. Final time to results would depend on the platform used, and the scale of 182 batching required to make the method cost effective. A recent study looked at real time analysis of 183 sequencing produced on the Oxford Nanopore MinION platform, showed it was possible to identify 184 the bacterial species in a sample within 30 minutes of starting the run. Initial resistance predictions 185 were ready within two hours, and all analysis was completed within 10 hours 41 . Combining good 186 sample preparation and real-time analysis could allow results to be obtained in a clinically actionable 187 time frame. In addition to the wet lab model, an analysis pipeline was developed to allow accurate 188 interpretation of the results. This included removal of contamination, normalisation of reads and LCA 189 analysis. Reference mapping and de novo assembly programmes were selected to give the best results 190 for the data produced, in terms of amplification using 29 MDA and sequencing on the 454 Junior. The use of 29 MDA was selected due to its ability to quickly and accurately amplify DNA 198 without the need for specific primers, allowing its application to a wide range of pathogens. 29 199 MDA has been associated with amplification bias, especially when starting from low input samples, 200 previously this was thought to be random, but has now been shown to be systemic 43 . Lower reaction 201 volumes have been shown to lower the effect of the bias, however significant scaling down from the 202 current 5 l starting material would be technically difficult. Use of digital droplet MDA has been 203 shown to give a more uniform coverage across the genome and lower none specific amplifcation 44 , 204 however this requires specialised equipment. For this study amplification bias was compensated for 205 bioinformatically, using a process of digital normalisation 33 , which removed over represented reads, 206
and added an additional error removal stage by removing very low level k-mers. This aided in 207 assembly of reads, as most assemblers assume even coverage across the genome, it also allowed the 208 data size to be reduced without loss of information. Despite the bias in the amplification, good 209 genome coverage and characterisation of the bacteria were achieved (89% and 93% gnome coverage 210 using de novo methods), with missing sections often being repeat elements within the genome. 211
The majority of sequencing reads from spiked horse blood were associated with the spiked bacteria 212 (62.1% S. aureus and 73% E. coli), considering the horse genome is over 500 times larger than the E. 213 coli genome this shows that the vast majority of the host material was removed. Overall there was 214 good concordance of phenotypic and genotypic results showing the potential for rapid genotypic 215 prediction of antibiotic resistance from 10 bacterial cells in 1 ml of host blood. In the S.aureus 216 sequencing the closest sub-species identified was Staphylococcus aureus subsp. aureus HO 5096 217 0412, this most likely represents the closest sequence in the reference database, rather than the actual 218 type of this organism. Antibiotic resistance predictions were concordant with the phenotypic results 219 except for ciprofloxacin. The inconclusive ciprofloxacin results demonstrate the need for improved 220 understanding of the mechanisms of resistance. Ciprofloxacin resistance is harder to predict as it isn't 221 associated with a single gene acquisition. Three mechanisms of fluoroquinolone resistance have been 222 proposed in S. aureus, Topoisomerase IV gene mutations, DNA gyrase gene mutations and an active 223 efflux pump (NorA) 45 . The complexity of predicting ciprofloxacin resistance suggests that the 224 database may be lacking in its ability to predict ciprofloxacin resistance, and so this is the most likely 225 cause of the inconclusive result for ciprofloxacin resistance. The developers of Mykrobe, a commonly 226 8 used antibiotic resistance predictor (Bradley et al 11 ) found a false negativity rate of 4.6% for 227 ciprofloxacin resistance. 228
In addition to identifying the isolates resistance to beta-lactams the database was able to identify the 229 blaZ gene and MecA gene. Genotypic testing will never entirely replace phenotypic susceptibility 230 testing, due to its inability to identify novel resistance determinants and the comprehensive nature of 231 phenotypic testing. However, in the case of invasive sepsis, the gain in speed provided by not having 232 to culture the organism to determine susceptibility could be life-saving. 233
Multiple antibiotic resistance factors were identified in the E. coli, which gave good concordance with 234 the phenotypic data. Using the genotypic data, it was possible to rapidly identify the beta-lactamase 235 present as BlaCMY-2. The rapid identification of the specific resistance genes in bacteria could help 236 identify outbreaks by providing more information than a simple antibiogram. Additionally, it could 237 help monitor resistance genes, to identify genes that are increasing in incidence. Large amounts of 238 horizontal genome transfer amongst Gram negative bacteria has the potential to cause outbreaks of 239 resistant bacteria through genes or plasmids 46 , which would be more complex to track. Rapid 240 identification of genes causing the resistance in isolates could help inform epidemiological and 241 outbreak studies which could involve several species of bacteria. A study of NGS sequencing data 242 from bacteraemia isolates of E. coli have shown resistance prediction specificity of 97% 2 , if this was 243 coupled with direct from sample sequencing genotypic prediction could inform treatment more 244 rapidly than phenotypic test. 245
This study demonstrates that de novo assembly methods can be used to identify bacterial species and 246 accurately predict antibiotic resistance. Lower coverage of the genomes after reference assembly 247 (92% and 93%), could reflect that references used were close but not exact matches to the clinical 248 isolates in the study, or the inability of short read assembly methods to assemble repeated elements 249 which are longer than the read length. The inability to subtype the E. coli strain most likely reflects 250 the large variety in E. coli genomes with the core genome representing only 13% of the pangenome 47 .
251
An earlier study by the authors, using E. coli K12 MG1655 gave genome coverage with 100% 252 sequence identity with the E. coli K12 MG1655 reference (data not shown). Clinical isolates rather 253 than fully characterised laboratory strains were selected to test the applicability of the analysis to 254 unknown samples. The ability to identify bacteria in a sample will be very dependent on the quality of 255 the database used, and results will be biased towards common pathogens, but this method should be 256 applicable to most bacteria found in clinical samples. 
